Mr. Trost joined Chimerix in 2011 as Senior Vice President and Chief Financial Officer, and has also served as Corporate Secretary since 2012. Prior to serving as an employee, since 2010, he had been working with Chimerix in a consulting capacity related to the Series F financing and Biomedical Advanced Research and Development Authority (BARDA). With more than 30 years of experience in the financial field, Mr. Trost last served as Vice President and CFO at Argos Therapeutics, Inc. (NASDAQ: ARGS), a previously venture-backed immunotherapy company located in Research Triangle Park. Previously, he was Senior Vice President and CFO at InteCardia, Inc., a venture-backed cardiac imaging company. While at InteCardia, Mr. Trost played a key role in negotiating and executing the sale of the company to Syncor International Corporation (NASDAQ: SCOR). Prior to InteCardia, Mr. Trost served as Executive Vice President and CFO of Coastal Physician Group, Inc. (NYSE: DR), a contract provider of emergency room physicians, having joined the company as Vice President of Corporate Development. He also held the position of Vice President of Finance at Morganite North America. Mr. Trost began his professional career with PricewaterhouseCoopers LLP, working in four offices over 12 years, including an international assignment, and last served as a Senior Manager in the Research Triangle practice. Mr. Trost holds a B.S. in Accounting from the University of Illinois at Urbana-Champaign and is a Certified Public Accountant.